MCS1A_XENLA
ID MCS1A_XENLA Reviewed; 181 AA.
AC Q5PPY1;
DT 22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT 04-JAN-2005, sequence version 1.
DT 03-AUG-2022, entry version 80.
DE RecName: Full=Malignant T-cell-amplified sequence 1-A;
DE Short=MCT-1A;
GN Name=mcts1-a;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Testis;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Plays a role as translation enhancer and involved in cell
CC cycle regulation. {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC -!- DOMAIN: The PUA RNA-binding domain is critical for cap binding, but not
CC sufficient for translation enhancer function. {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the MCTS1 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC087444; AAH87444.1; -; mRNA.
DR EMBL; BC106233; AAI06234.1; -; mRNA.
DR RefSeq; NP_001089037.1; NM_001095568.1.
DR AlphaFoldDB; Q5PPY1; -.
DR SMR; Q5PPY1; -.
DR BioGRID; 106503; 1.
DR IntAct; Q5PPY1; 1.
DR DNASU; 503679; -.
DR GeneID; 503679; -.
DR KEGG; xla:503679; -.
DR CTD; 503679; -.
DR Xenbase; XB-GENE-998587; mcts1.S.
DR OMA; HDHIEIL; -.
DR OrthoDB; 1257440at2759; -.
DR Proteomes; UP000186698; Chromosome 8S.
DR Bgee; 503679; Expressed in oocyte and 19 other tissues.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0003723; F:RNA binding; IEA:InterPro.
DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR GO; GO:0040008; P:regulation of growth; IEA:UniProtKB-KW.
DR InterPro; IPR016437; MCT-1/Tma20.
DR InterPro; IPR041366; Pre-PUA.
DR InterPro; IPR002478; PUA.
DR InterPro; IPR015947; PUA-like_sf.
DR InterPro; IPR004521; Uncharacterised_CHP00451.
DR PANTHER; PTHR22798; PTHR22798; 1.
DR Pfam; PF17832; Pre-PUA; 1.
DR Pfam; PF01472; PUA; 1.
DR PIRSF; PIRSF005067; Tma_RNA-bind_prd; 1.
DR SMART; SM00359; PUA; 1.
DR SUPFAM; SSF88697; SSF88697; 1.
DR TIGRFAMs; TIGR00451; unchar_dom_2; 1.
DR PROSITE; PS50890; PUA; 1.
PE 2: Evidence at transcript level;
KW Cell cycle; Cytoplasm; Growth regulation; Reference proteome;
KW Transcription; Transcription regulation.
FT CHAIN 1..181
FT /note="Malignant T-cell-amplified sequence 1-A"
FT /id="PRO_0000344792"
FT DOMAIN 92..171
FT /note="PUA"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00161"
SQ SEQUENCE 181 AA; 20530 MW; 58F8D101F49712F0 CRC64;
MFKKFDEKEN VSNCIQLKTS VIKGIKNQLI DQFPGIEQWL NQIMPKKDPV KIVRCHEHIE
ILTVNGELLF FRQREGPFYP TLRLLHKYPF ILPHQQVDKG AIKFVLSGAN IMCPGLTSPG
AKLYPAAADT VVAIMAEGKQ HALCVGVMKM SADDIEKINK GIGIENIHYL NDGLWHMKTY
K